We also identified groups that contained validated prostate cancer oncogenes with novel associations, such as SOX4, a prostate cancer transforming oncogene, and FOXA2 and GATA4, known pioneer factors (oTFCG13, Table 1) [25]. The gene discussed is FOXA2; the disease is Familial prostate cancer.